29.05.2024  17:12:01 Zm. -0,045 Wolumen Bid17:12:05 Ask17:12:05 Kapitalizacja Rynkowa St. dywidendy Wskaźnik C/Z
0,975EUR -4,41% 0
Obrót: 0.000
0,850Wolumen Bid: 7 700 1,100Wolumen Ask: 5 950 7,03 mlnEUR 0,00% -

Opis działalności

Bio-Gate is a medical technology company that employs unique silver technology to endow materials and products with antimicrobial properties. The focus of the product portfolio is medical technology products. Bio-Gate technology is based on the antimicrobial activity of silver ions. The company employs only pure metallic silver. Bio-Gate uses two different technologies. In the first, silver particles are incorporated into cosmetics, paints, veneers or plastics. The second involves coating final products - such as implants or wound dressings - with a silver-containing functional layer. Both technologies use extremely small particles of silver, to ensure that as many silver ions as possible are released.
 

Zarząd & Rada nadzorcza

CEO
Marc Lloret-Grau
Zarząd
Thomas Konradt
Rada nadzorcza
Karl Richter, Volker Rofalski, Prof. Dr. Dr. Volker Alt
 

Dane firmy

Nazwa: Bio-Gate AG
Adres: Neumeyerstraße 28-34,D-90411 Nürnberg
Telefon: +49-911-4775-23–100
Fax: +49-911-4775-23–101
E-mail: info@bio-gate.de
Internet: www.bio-gate.de/
Przemysł: Służba zdrowia
Sektor: Produkty Medyczne
Podsektor: Zaawansowane Urządzenia Medyczne
Koniec roku finansowego: 31.12
Free float: 18,30%
Data IPO: 05.04.2006

Relacje inwestorskie

Nazwa: Gerd Rückel
Telefon: +49-6172-807-309
Fax: -
E-mail: presse@bio-gate.de

Główni akcjonariusze

Synthos GmbH
 
46,30%
Freefloat
 
18,30%
Mountain Technology AG
 
15,80%
Eiffel Investment Group
 
8,40%
Richter / RFH Ltd.
 
7,30%
Gründer / Management
 
3,90%